Lutz Holger H, Ackermann Thomas, Krombach Gabriele A, Gröne Hermann-Josef, Rauen Thomas, Floege Jürgen, Mertens Peter R
Department of Hepatology and Gastroenterology, University Hospital RWTH-Aachen, Aachen, Germany.
Am J Kidney Dis. 2009 Nov;54(5):e9-15. doi: 10.1053/j.ajkd.2009.04.017. Epub 2009 Jun 17.
Involvement of the kidneys in Henoch-Schönlein purpura (HSP) occurs in approximately 50% of patients with HSP, with varying severity. In general, disease outcome is favorable for adolescents. However, severe courses with vasculitis impairing multiple organ systems in addition to the kidney, including brain, heart, and intestine, may occur. This involvement, often manifesting more subtly, requires alertness for diagnosis and escalation of immunosuppressive therapy for treatment. We report a case of severe HSP nephritis with cardiac involvement in a young man. Cardiac involvement was noted initially on an electrocardiogram and visualized by using cardiac magnetic resonance imaging. HSP remission was induced with aggressive cytotoxic therapy, consisting of cyclophosphamide (750 mg/m(2) every 4 weeks) in addition to high-dose prednisolone. The case presentation is followed by a review of the literature for manifestations, treatments, and outcomes in patients with HSP complicated by cardiac involvement.
过敏性紫癜(HSP)累及肾脏的情况约发生在50%的HSP患者中,严重程度各异。一般来说,青少年的疾病预后良好。然而,除肾脏外,血管炎累及包括脑、心脏和肠道在内的多个器官系统的严重病程也可能发生。这种累及往往表现得较为隐匿,需要提高诊断警惕性并加强免疫抑制治疗。我们报告一例年轻男性严重HSP肾炎合并心脏受累的病例。心脏受累最初通过心电图发现,并通过心脏磁共振成像得以可视化。采用积极的细胞毒性疗法诱导HSP缓解,该疗法除大剂量泼尼松龙外,还包括环磷酰胺(每4周750 mg/m²)。病例报告之后是对HSP合并心脏受累患者的临床表现、治疗方法及预后的文献综述。